Financial Year |
March 31 2023 |
Monetary Funds |
159,032,170.67 |
Held-for-trading Financial Assets |
150,093,611.88 |
Notes Receivable |
388,000.00 |
Accounts Receivable |
94,683,175.42 |
Advances to Suppliers |
1,729,010.06 |
Other Receivables |
1,345,388.15 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
64,317,967.33 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
576,849.84 |
Total Current Assets |
497,687,470.07 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
117,831,326.85 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
17,214,091.10 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
4,424,805.98 |
Other Non-Current Assets |
169,734.51 |
Sub-Total of Non-Current Assets |
139,639,958.44 |
Total Assets |
637,327,428.51 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
10,920,414.31 |
Accounts Payable |
67,980,584.44 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
7,516,894.65 |
Taxes Payable |
1,740,099.94 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,136,568.95 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
459,853.57 |
Sub-Total of Current Liabilities |
112,980,387.51 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
-- |
Total Liabilities |
112,980,387.51 |
Paid-In Capital(Or Share Stock) |
128,000,000.00 |
Capital Surplus |
116,067,253.50 |
Surplus Reserve |
32,013,261.01 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
248,266,526.49 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
524,347,041.00 |
Owner's Equity(Stockholder's Equity) |
524,347,041.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
637,327,428.51 |